Is brown adipose tissue a new target for obesity therapy?
https://doi.org/10.15829/1728-8800-2021-2860
Abstract
The rapid increase in the prevalence of obesity and related diseases has prompted researchers to seek novel effective therapeutic targets. Recently, brown adipose tissue has been in the spotlight as a potential target for treatment of metabolic diseases due to its ability to increase energy expenditure and regulate glucose and lipid homeostasis. The review presents the latest data on approaches aimed at activating and expanding brown adipose tissue in order to combat obesity.
About the Authors
O. M. Drapkina
National Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Moscow.
O. T. Kim
National Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Moscow.
Tel.: +7 (901) 507-49-87
References
1. Inoue Y, Qin B, Poti J, et al. Epidemiology of Obesity in Adults: Latest Trends. Curr Obes Rep. 2018;7(4):276-88. doi:10.1007/s13679-018-0317-8.
2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128-9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42. doi:10.1016/S0140-6736(17)32129-3.
3. Gadde KM, Martin CK, Berthoud HR, et al. Obesity: Pathophysiology and Management. J Am Coll Cardiol. 2018;71(1):69-84. doi:10.1016/j.jacc.2017.11.011.
4. Moonen MPB, Nascimento EBM, van Marken Lichtenbelt WD. Human brown adipose tissue: Underestimated target in metabolic disease? Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(1):104-12. doi:10.1016/j.bbalip.2018.05.012.
5. Chechi K, van Marken Lichtenbelt W, Richard D. Brown and beige adipose tissues: phenotype and metabolic potential in mice and men. J Appl Physiol (1985). 2018;124(2):482-96. doi: 10.1152/23.japplphysiol.00021.2017.
6. Chondronikola M, Volpi E, B0rsheim E, et al. Brown Adipose Tissue Activation Is Linked to Distinct Systemic Effects on 24. Lipid Metabolism in Humans. Cell Metab. 2016;23(6):1200-6. doi:10.1016/j.cmet.2016.04.029.
7. Zoico E, Rubele S, De Caro A, et al. Brown and Beige Adipose Tissue and Aging. Front Endocrinol (Lausanne). 2019;10:368. doi:10.3389/fendo.2019.00368.
8. Wang W, Seale P. Control of brown and beige fat development. Nat Rev Mol Cell Biol. 2016;17(11):691-702. doi:10.1038/nrm.2016.96.
9. Oiwa Y, Oka K, Yasui H, et al. Characterization of brown adipose tissue thermogenesis in the naked mole-rat (Heterocephalus glaber), a heterothermic mammal. Sci Rep. 2020;10(1):19488. doi:10.1038/s41598-020-74929-6.
10. Koksharova EO, Mayorov AYu, Shestakova MV, et al. Metabolic characteristics and therapeutic potential of brown and beige adipose tissues. Diabetes mellitus. 2014;17(4):5-15. (In Russ.)
11. Timmons JA, Wennmalm K, Larsson O, et al. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci USA. 2007;104(11):4401-6. doi:10.1073/pnas.0610615104.
12. Long JZ, Svensson KJ, Tsai L, et al. A smooth muscle-like origin for beige adipocytes. Cell Metab. 2014;19(5):810-20. doi:10.1016/j.cmet.2014.03.025.
13. Egorov AD, Penkov DN, Tkachuk VA. Molecular and cellular mechanisms of adipogenesis. Diabetes mellitus. 2015;18(2):12-9. (In Russ.)
14. Carpentier AC, Blondin DP, Virtanen KA, et al. Brown Adipose Tissue Energy Metabolism in Humans. Front Endocrinol (Lausanne). 2018;9:447. doi:10.3389/fendo.2018.00447.
15. Liu J, Wang Y, Lin L. Small molecules for fat combustion: targeting obesity. Acta Pharm Sin B. 2019;9(2):220-36. doi:10.1016/j.apsb.2018.09.007.
16. Finlin BS, Memetimin H, Zhu B, et al. The вЗ-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. J Clin Invest. 2020;130(5):2319-31. doi:10.1172/JCI134892.
17. O'Mara AE, Johnson JW, Linderman JD, et al. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest. 2020;130(5):2209-19. doi:10.1172/JCI131126.
18. Yau WW, Yen PM. Thermogenesis in Adipose Tissue Activated by Thyroid Hormone. Int J Mol Sci. 2020;21(8):3020. doi:10.3390/ijms21083020.
19. Amorim BS, Ueta CB, Freitas BC, et al. A TRbeta-selective agonist confers resistance to diet-induced obesity. J Endocrinol. 2009;203(2):291-9. doi:10.1677/JOE-08-0539.
20. Villicev CM, Freitas FR, Aoki MS, et al. Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. J Endocrinol. 2007;193(1):21-9. doi:10.1677/joe.1.07066.
21. Broeders EP, Nascimento EB, Havekes B, et al. The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity. Cell Metab. 2015;22(3):418-26. doi:10.1016/j.cmet.2015.07.002.
22. Chevalier C, Stojanovic O, Colin DJ, et al. Gut Microbiota Orchestrates Energy Homeostasis during Cold. Cell. 2015;163(6):1360-74. doi:10.1016/j.cell.2015.11.004.
23. Li B, Li L, Li M, et al. Microbiota Depletion Impairs Thermogenesis of Brown Adipose Tissue and Browning of White Adipose Tissue. Cell Rep. 2019;26(10):2720-37.e5. doi:10.1016/j.celrep.2019.02.015.
24. Fabbiano S, Suarez-Zamorano N, Chevalier C, et al. Functional Gut Microbiota Remodeling Contributes to the Caloric Restriction-Induced Metabolic Improvements. Cell Metab. 2018;28(6):907-21. e7. doi:10.1016/j.cmet.2018.08.005.
25. Cornejo-Pareja I, Munoz-Garach A, Clemente-Postigo M, et al. Importance of gut microbiota in obesity. Eur J Clin Nutr. 2019;72(Suppl 1):26-37. doi:10.1038/s41430-018-0306-8.
26. Arhire LI, Mihalache L, Covasa M. Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome. Front Endocrinol (Lausanne). 2019;10:524. doi:10.3389/fendo.2019.00524.
27. Dong J, Dong Y, Dong Y, et al. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues. Int J Obes (Lond). 2016;40(3):434-42. doi:10.1038/ijo.2015.200.
28. Roberts LD, Bostrom P, O'Sullivan JF, et al. в-Aminoisobutyric acid induces browning of white fat and hepatic в-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 2014;19(1):96-108. doi:10.1016/j.cmet.2013.12.003.
29. Cuevas-Ramos D, Mehta R, Aguilar-Salinas CA. Fibroblast Growth Factor 21 and Browning of White Adipose Tissue. Front Physiol. 2019;10:37. doi:10.3389/fphys.2019.00037.
30. Zheng SL, Li ZY, Song J, et al. Metrnl: a secreted protein with new emerging functions. Acta Pharmacol Sin. 2016;37(5):571-9. doi:10.1038/aps.2016.9.
31. Tremblay A, Arguin H, Panahi S. Capsaicinoids: a spicy solution to the management of obesity? Int J Obes (Lond). 2016;40(8):1198-204. doi:10.1038/ijo.2015.253.
32. Baskaran P, Krishnan V, Ren J, et al. Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel-dependent mechanisms. Br J Pharmacol. 2016;173(15):2369-89. doi:10.1111/bph.13514.
33. Snitker S, Fujishima Y, Shen H, et al. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr. 2009;89(1):45-50. doi:10.3945/ajcn.2008.26561.
34. Huang J, Wang Y, Xie Z, et al. The anti-obesity effects of green tea in human intervention and basic molecular studies. Eur J Clin Nutr. 2014 Oct;68(10):1075-87. doi:10.1038/ejcn.2014.143.
35. Kurogi M, Kawai Y, Nagatomo K, et al. Auto-oxidation products of epigallocatechin gallate activate TRPA1 and TRPV1 in sensory neurons. Chem Senses. 2015;40(1):27-46. doi:10.1093/chemse/bju057.
36. Saito M, Matsushita M, Yoneshiro T, et al. Brown Adipose Tissue, Diet-Induced Thermogenesis, and Thermogenic Food Ingredients: From Mice to Men. Front Endocrinol (Lausanne). 2020;11:222. doi:10.3389/fendo.2020.00222.
37. Steensels S, Ersoy BA. Fatty acid activation in thermogenic adipose tissue. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(1):79-90. doi:10.1016/j.bbalip.2018.05.008.
38. Kim M, Goto T, Yu R, et al. Fish oil intake induces UCP1 upregulation in brown and white adipose tissue via the sympathetic nervous system. Sci Rep. 2015;5:18013. doi:10.1038/srep18013.
39. Payab M, Abedi M, Foroughi Heravani N, et al. Brown adipose tissue transplantation as a novel alternative to obesity treatment: a systematic review. Int J Obes (Lond). 2021;45(1):109-21. doi:10.1038/s41366-020-0616-5.
40. Soler-Vazquez MC, Mera P, Zagmutt S, et al. New approaches targeting brown adipose tissue transplantation as a therapy in obesity. Biochem Pharmacol. 2018;155:346-55. doi:10.1016/j.bcp.2018.07.022.
Supplementary files
Review
For citations:
Drapkina O.M., Kim O.T. Is brown adipose tissue a new target for obesity therapy? Cardiovascular Therapy and Prevention. 2021;20(5):2860. (In Russ.) https://doi.org/10.15829/1728-8800-2021-2860
Views:
13227
Email this article 
